Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Gelderblom

Showing results (21-30 of 488) with videos related to

Pageof 49
Sort By:
Current Oncology (Toronto, Ont.)|July 26, 2024
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Hans Gelderblom, et al.
Cancer Treatment Reviews|September 8, 2009
Clinical pharmacokinetics of tyrosine kinase inhibitorsNielka P van Erp, Hans Gelderblom, Henk-Jan Guchelaar
Clinical Sarcoma Research|August 16, 2014
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013Annemiek M van Maldegem, Judith Vmg Bovée, Hans Gelderblom
Drug Discovery Today|July 3, 2010
Therapeutic modulation of k-ras signaling in colorectal cancerLisanne L Krens, Jara M Baas, Hans Gelderblom, et al.
Critical Reviews in Oncology/Hematology|May 15, 2020
The significance of stromal collagen organization in cancer tissue: An in-depth discussion of literatureStéphanie M Zunder, Hans Gelderblom, Rob A Tollenaar, et al.
BMJ Open|May 10, 2022
Short-term and long-term prognostic value of histological response and intensified chemotherapy in osteosarcoma: a retrospective reanalysis of the BO06 trialEni Musta, Nan van Geloven, Jakob Anninga, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2020
Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime timeEmma C Hulshof, Maarten J Deenen, Henk-Jan Guchelaar, et al.
Clinical Pharmacokinetics|July 23, 2013
Breath tests to phenotype drug disposition in oncologyFrans L Opdam, Anil S Modak, Hans Gelderblom, et al.
Pediatric Blood & Cancer|June 2, 2016
Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case ReportAnnemiek M van Maldegem, Judith V M G Bovée, Hans Gelderblom
Journal of Biomedical Informatics|October 29, 2022
How do others cope? Extracting coping strategies for adverse drug events from social mediaAnne Dirkson, Suzan Verberne, Gerard van Oortmerssen, et al.
Pageof 49

Showing results (21-30 of 488) with videos related to

Sort By:
Pageof 49
Current Oncology (Toronto, Ont.)|July 26, 2024
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Hans Gelderblom, et al.
Cancer Treatment Reviews|September 8, 2009
Clinical pharmacokinetics of tyrosine kinase inhibitorsNielka P van Erp, Hans Gelderblom, Henk-Jan Guchelaar
Clinical Sarcoma Research|August 16, 2014
Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013Annemiek M van Maldegem, Judith Vmg Bovée, Hans Gelderblom
Drug Discovery Today|July 3, 2010
Therapeutic modulation of k-ras signaling in colorectal cancerLisanne L Krens, Jara M Baas, Hans Gelderblom, et al.
Critical Reviews in Oncology/Hematology|May 15, 2020
The significance of stromal collagen organization in cancer tissue: An in-depth discussion of literatureStéphanie M Zunder, Hans Gelderblom, Rob A Tollenaar, et al.
BMJ Open|May 10, 2022
Short-term and long-term prognostic value of histological response and intensified chemotherapy in osteosarcoma: a retrospective reanalysis of the BO06 trialEni Musta, Nan van Geloven, Jakob Anninga, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2020
Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime timeEmma C Hulshof, Maarten J Deenen, Henk-Jan Guchelaar, et al.
Clinical Pharmacokinetics|July 23, 2013
Breath tests to phenotype drug disposition in oncologyFrans L Opdam, Anil S Modak, Hans Gelderblom, et al.
Pediatric Blood & Cancer|June 2, 2016
Panobinostat-A Potential Treatment for Metastasized Ewing Sarcoma? A Case ReportAnnemiek M van Maldegem, Judith V M G Bovée, Hans Gelderblom
Journal of Biomedical Informatics|October 29, 2022
How do others cope? Extracting coping strategies for adverse drug events from social mediaAnne Dirkson, Suzan Verberne, Gerard van Oortmerssen, et al.
Pageof 49